engleski

Prolongation of Finasteride therapy may promote aggressive prostate cancer

Continuous Finasteride therapy in BPH patients leads to the elevation in an aggressive prostate cancer findings than in patients who use the same drug in an intermittend way (only 6-9 months). Countinuous adnministration of this drug causes the raise in serum CgA level and an increase in neuroendocrine differentiation.

BPH; finasteride therapy; couninuous or intermittend; aggressive prostate cancer; CgA values

nije evidentirano